All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.
Categories
Recent Posts
CJC-1295 Peptide Research: GHRH Analog and Growth Hormone
Explore CJC-1295, a GHRH analog originally developed as an investigational compound. Studies have measured its effects on growth hormone and IGF-1 levels.
PP-TS1: GHRH Analog Research
PP-TS1 is a growth hormone-releasing hormone analog studied for its stability, GHRH-receptor pharmacology and GH/IGF-1 responses. A summary of the published literature.
Peptides and Aging Biology: A Research Overview
Peptides are gaining attention as research tools in aging biology. These short chains of amino acids regulate cellular repair, inflammation, and hormonal balance, processes that are studied in research on age-related conditions. Recent research has examined their interactions with aging mechanisms. This article explores peptides’ role in aging biology research and the challenges facing this field.
Delta-Sleep-Inducing Peptide (DSIP): Research Summary
Brief Overview/Summary
Explore research on Delta Sleep-Inducing Peptide (DSIP), its role in sleep regulation, and its influence on circadian rhythms through scientific studies.
Delta sleep-inducing peptide (DSIP, TrpAlaGlyGlyAspAlaSerGlyGlu) has been known since the late 1970s. It was isolated by the Schoenenberger–Monnier group in Basel from the cerebral venous blood of rabbits and was characterised as a nonapeptide that enhanced delta (slow-wave) EEG activity in rabbits [1][2]. It was later reported to influence sleep in several other animal species [3].
While further research was not able to establish DSIP as a sleep factor, it did reveal a variety of other effects. Reviews describe activity on electrophysiological measures, brain neurotransmitter levels, circadian and locomotor patterns, hormone levels and stress responses [2][3].
Mechanism of Action of Delta-Sleep-Inducing Peptide (DSIP)
The stress-protective effects reported for DSIP in animal studies may be connected to its influence on the energy metabolism of mitochondria [4]. Mitochondria are considered especially sensitive to stress conditions, which is why they are a focus of research on stress-induced metabolic disturbances [4].
In isolated rat brain mitochondria, DSIP increased the rate of phosphorylated (state 3) respiration, the respiratory control ratio and the rate of ADP phosphorylation, indicating more efficient oxidative phosphorylation. In rats exposed to hypoxia, prior DSIP exposure prevented the hypoxia-induced fall in mitochondrial respiratory activity [4]. In another rat hypoxia model, DSIP partially limited stress-induced changes in the activity of the mitochondrial enzyme monoamine oxidase A (MAO-A) and in brain serotonin levels [5].
Research Evidence of Delta-Sleep-Inducing Peptide (DSIP)
Experiments on animals have reported that the sleep-related effects of DSIP differ between species: reviews describe mainly delta-sleep effects in rabbits, rats and mice, whereas in cats the effect on REM sleep was more pronounced [3]. In freely moving rabbits, synthetic DSIP increased cortical delta activity and decreased motor activity for several hours, which the authors took as evidence that the peptide crosses the blood–brain barrier [6].
Later work did not settle the question. A 2006 review notes that the link between DSIP and sleep was never characterised further, in part because the DSIP gene, precursor protein and receptor have not been isolated, and that in the authors' own early studies certain synthetic DSIP analogues, but not DSIP itself, showed significant slow-wave-sleep-promoting activity in rabbits and rats [2].
In rats, DSIP was associated with changes over the following 24 hours in brain serotonin, dopamine and norepinephrine and in plasma proteins and corticosterone. The changes differed with the time of day at which the peptide was given, and the authors tentatively described these effects as "programming functions" within the 24-hour rest–activity period [7].
DSIP has also been studied in stress-hormone research. In rats, DSIP reduced corticotropin-releasing factor (CRF)-stimulated corticosterone release but did not affect corticosterone release elicited by adrenocorticotropic hormone, suggesting an action at the level of the pituitary [8].
Research Applications of Delta-Sleep-Inducing Peptide (DSIP)
The original discovery came from rabbit experiments in which dialysates of blood from donor rabbits in a state of electrically induced sleep caused recipient rabbits to enter delta (slow-wave) sleep. This effect was attributed to a nonapeptide, DSIP, which was isolated from these dialysates and characterised [1][3].
DSIP-like material has since been measured in the brain, in peripheral organs of the rat and in the plasma of several mammals [3]. In rats, plasma DSIP-like immunoreactivity showed a circadian rhythm that paralleled corticosterone, with peak levels at about 17:00, and constant illumination abolished this rhythm [9].
Brain and plasma levels of immunoactive DSIP in rats also varied with the light–dark cycle, and blood–brain barrier permeability to labelled DSIP was higher in rats kept in constant light or constant dark [10].
DSIP is often studied alongside other peptides studied in sleep research because of its history as a candidate sleep factor. In the rat studies described above, its effects extended to cerebral neurotransmitters and plasma proteins, which is why it is also of interest in neuroendocrine research [7].
Future Perspective for DSIP
Delta-sleep-inducing peptide (DSIP) remains a subject of sleep and neuroendocrine research, but several basic questions are still open: how it is naturally synthesised and released, which receptor it acts through, and whether a related, not yet identified DSIP-like peptide accounts for part of the DSIP-like immunoreactivity and activity described in the literature [2].
Sleep regulation research: whether DSIP, its analogues or a DSIP-like peptide contribute to the regulation of slow-wave sleep remains an open question [2].
Other physiological roles: in addition to sleep regulation, research may further investigate the possible roles of DSIP in stress responses and neuroendocrine regulation, which rat studies have linked to corticosterone, neurotransmitter and circadian measures [7][8][9].
Studies on the mechanism of action: more research is necessary to understand how DSIP interacts with its receptor(s) and the downstream signalling pathways involved in its effects [2].
Blood–brain barrier transport: studies in rabbits and rats have examined how DSIP crosses the blood–brain barrier and how this transport varies with physiological factors such as the light–dark cycle [6][10].
Genetic and molecular investigations: identifying the gene responsible for the production of DSIP, and how it is regulated in the central nervous system, could give insight into the systems that control sleep–wake cycles [2].
Possible restrictions: The receptor through which DSIP acts has not been identified, its natural occurrence and biological role remain unclear, and findings on its sleep-promoting activity have differed between laboratories and species [2][3]. In general, DSIP remains a subject of sleep research, and more research is needed to better understand how it works.
References
Schoenenberger GA, Maier PF, Tobler JH, Monnier M. (1977). A naturally occurring delta-EEG enhancing nonapeptide in rabbits. X. Final isolation, characterization and activity test. Pflügers Archiv, 369(2), 99–109. https://doi.org/10.1007/BF00591565
Kovalzon VM, Strekalova TV. (2006). Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry, 97(2), 303–309. https://doi.org/10.1111/j.1471-4159.2006.03693.x
Graf MV, Kastin AJ. (1984). Delta-sleep-inducing peptide (DSIP): a review. Neuroscience and Biobehavioral Reviews, 8(1), 83–93. https://doi.org/10.1016/0149-7634(84)90022-8
Khvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II. (2003). Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia. Peptides, 24(2), 307–311. https://doi.org/10.1016/s0196-9781(03)00040-8
Khvatova EM, Rubanova NA, Prudchenko IA, Mikhaleva II. (1995). Effects of delta-sleep inducing peptide (DSIP) and some analogues on the activity of monoamine oxidase type A in rat brain under hypoxia stress. FEBS Letters, 368(2), 367–369. https://doi.org/10.1016/0014-5793(95)00661-r
Monnier M, Dudler L, Gächter R, Schoenenberger GA. (1977). Transport of the synthetic peptide DSIP through the blood-brain barrier in rabbit. Experientia, 33(12), 1609–1610. https://doi.org/10.1007/BF01934026
Graf M, Baumann JB, Girard J, Tobler HJ, Schoenenberger GA. (1982). DSIP-induced changes of the daily concentrations of brain neurotransmitters and plasma proteins in rats. Pharmacology Biochemistry and Behavior, 17(3), 511–517. https://doi.org/10.1016/0091-3057(82)90312-4
Graf MV, Kastin AJ, Coy DH, Fischman AJ. (1985). Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. Neuroendocrinology, 41(4), 353–356. https://doi.org/10.1159/000124200
Fischman AJ, Kastin AJ, Graf MV. (1984). Circadian variation of DSIP-like material in rat plasma. Life Sciences, 35(20), 2079–2084. https://doi.org/10.1016/0024-3205(84)90566-6
Banks WA, Kastin AJ, Selznick JK. (1985). Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm. Journal of Neuroscience Research, 14(3), 347–355. https://doi.org/10.1002/jnr.490140307
Read more about peptides

Thymosin Alpha-1 Peptide: Immune Modulation & T-Cell Research
Explore research on Thymosin Alpha-1 peptide, its role in immune system modulation and T-cell development through scientific studies
PT-141 Peptide: Bremelanotide as a Melanocortin Agonist
Investigate studies on PT-141 peptide (Bremelanotide) and its activity at melanocortin receptors, particularly the melanocortin 4 receptor (MC4R).